Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
LO ›
LOREXYS
Trademark search for:
LOREXYS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-03-20 — Application filed
2017-03-23 — Application filed
2017-03-23 — Application filed
2017-06-13 — Assigned to examiner
2017-06-14 — Approved for pub - principal register
2017-07-05 — Notification of notice of publication e-mailed
2017-07-25 — Published for opposition
2017-07-25 — Official gazette publication confirmation e-mailed
2017-09-19 — Noa e-mailed - sou required from applicant
2018-03-06 — Teas revoke/app/change addr of atty/dom rep received
2018-03-06 — Attorney/dom.rep.revoked and/or appointed
2018-03-13 — Sou teas extension received
2018-03-13 — Sou extension 1 filed
2018-03-13 — Sou extension 1 granted
2018-03-15 — Notice of approval of extension request e-mailed
2018-09-17 — Sou teas extension received
2018-09-17 — Sou extension 2 filed
2018-09-17 — Sou extension 2 granted
2018-09-19 — Notice of approval of extension request e-mailed
2019-03-18 — Sou teas extension received
2019-03-18 — Sou extension 3 filed
2019-03-18 — Sou extension 3 granted
2019-03-20 — Notice of approval of extension request e-mailed
2019-10-21 — Application abandoned
2019-10-21 — Application abandoned
2019-10-21 — Final status recorded
Owner Information
S1 Biopharma, Inc.
New York , NY
S1 Biopharma, Inc.
New York , NY
Correspondent
Peter Manso Lewis Brisbois Bisgaard & Smith LLP 550 W. Adams Street, Suite 300 Chicago, IL 60661 UNITED STATES
Filing Details
Filing Date:
2017-03-20
Status Date:
2019-10-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.